Misplaced Pages

Xanthinol: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 17:00, 6 October 2021 editSkullcinema (talk | contribs)Extended confirmed users2,796 edits cite patent fix← Previous edit Latest revision as of 03:11, 1 October 2022 edit undoHouseBlaster (talk | contribs)Edit filter managers, Administrators59,531 editsm Disambiguating links to Niacin (link changed to Niacin (substance)) using DisamAssist. 
Line 48: Line 48:
}} }}


'''Xanthinol''' is a drug prepared from ] used as a ].<ref>{{cite patent | title = 3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol. | inventor = Yokoyama M, Kawano S | pubdate = 1963 | country = JA | number = 38020588 }}</ref><ref>{{cite book | vauthors = Morton IK, Hall JM |title=Concise dictionary of pharmacological agents : properties and synonyms |date=1999 |publisher=Kluwer Academic |location=Boston |isbn=978-0-7514-0499-9 |page=294}}</ref> It is most often used as the ] with ] (nicotinic acid), known as xanthinol nicotinate.<ref>{{cite web | url = http://cancerweb.ncl.ac.uk/cgi-bin/omd?xanthinol+niacinate | title = Xanthinol niacinate] | work = cancerweb.ncl.ac.uk }}</ref> '''Xanthinol''' is a drug prepared from ] used as a ].<ref>{{cite patent | title = 3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol. | inventor = Yokoyama M, Kawano S | pubdate = 1963 | country = JA | number = 38020588 }}</ref><ref>{{cite book | vauthors = Morton IK, Hall JM |title=Concise dictionary of pharmacological agents : properties and synonyms |date=1999 |publisher=Kluwer Academic |location=Boston |isbn=978-0-7514-0499-9 |page=294}}</ref> It is most often used as the ] with ] (nicotinic acid), known as xanthinol nicotinate.<ref>{{cite web | url = http://cancerweb.ncl.ac.uk/cgi-bin/omd?xanthinol+niacinate | title = Xanthinol niacinate] | work = cancerweb.ncl.ac.uk }}</ref>


==References== ==References==

Latest revision as of 03:11, 1 October 2022

Chemical compound Pharmaceutical compound
Xanthinol
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • 7--1,3-dimethylpurine-2,6-dione
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21N5O4
Molar mass311.342 g·mol
3D model (JSmol)
SMILES
  • O=C2N(c1ncn(c1C(=O)N2C)CC(O)CN(CCO)C)C
InChI
  • InChI=1S/C13H21N5O4/c1-15(4-5-19)6-9(20)7-18-8-14-11-10(18)12(21)17(3)13(22)16(11)2/h8-9,19-20H,4-7H2,1-3H3
  • Key:DSFGXPJYDCSWTA-UHFFFAOYSA-N
  (what is this?)  (verify)

Xanthinol is a drug prepared from theophylline used as a vasodilator. It is most often used as the salt with niacin (nicotinic acid), known as xanthinol nicotinate.

References

  1. JA 38020588, Yokoyama M, Kawano S, "3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol.", published 1963 
  2. Morton IK, Hall JM (1999). Concise dictionary of pharmacological agents : properties and synonyms. Boston: Kluwer Academic. p. 294. ISBN 978-0-7514-0499-9.
  3. "Xanthinol niacinate]". cancerweb.ncl.ac.uk.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories:
Xanthinol: Difference between revisions Add topic